Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALVR |
---|---|---|
09:32 ET | 1197 | 0.79242 |
09:38 ET | 100 | 0.761 |
09:45 ET | 800 | 0.771886 |
09:48 ET | 100 | 0.765 |
09:50 ET | 100 | 0.765 |
09:52 ET | 300 | 0.7723 |
09:54 ET | 200 | 0.765 |
09:56 ET | 7100 | 0.7795 |
09:57 ET | 5100 | 0.7551 |
10:01 ET | 100 | 0.76 |
10:03 ET | 100 | 0.76 |
10:08 ET | 360 | 0.7795 |
10:12 ET | 200 | 0.76 |
10:15 ET | 100 | 0.76 |
10:19 ET | 100 | 0.76 |
10:24 ET | 200 | 0.76 |
10:26 ET | 200 | 0.76975 |
10:35 ET | 200 | 0.76 |
10:39 ET | 200 | 0.76 |
10:42 ET | 229 | 0.7601 |
10:46 ET | 100 | 0.76 |
10:50 ET | 100 | 0.76 |
10:53 ET | 100 | 0.76 |
10:55 ET | 10450 | 0.7651 |
10:57 ET | 100 | 0.76 |
11:08 ET | 200 | 0.7672 |
11:11 ET | 200 | 0.76 |
11:18 ET | 100 | 0.76 |
11:22 ET | 100 | 0.76 |
11:27 ET | 200 | 0.76 |
11:29 ET | 300 | 0.76585 |
11:33 ET | 100 | 0.76 |
11:49 ET | 100 | 0.7601 |
11:51 ET | 640 | 0.771 |
11:58 ET | 5300 | 0.76 |
12:02 ET | 100 | 0.7551 |
12:03 ET | 200 | 0.7551 |
12:05 ET | 1728 | 0.75815 |
12:07 ET | 300 | 0.7611 |
12:18 ET | 179 | 0.7583 |
12:27 ET | 332 | 0.7552 |
12:34 ET | 100 | 0.7552 |
12:39 ET | 100 | 0.7552 |
12:43 ET | 300 | 0.7552 |
12:50 ET | 100 | 0.7552 |
12:56 ET | 100 | 0.7552 |
01:01 ET | 200 | 0.761 |
01:03 ET | 232 | 0.7611 |
01:10 ET | 59464 | 0.74999 |
01:14 ET | 9538 | 0.75 |
01:17 ET | 23292 | 0.7409 |
01:19 ET | 6200 | 0.74 |
01:21 ET | 19800 | 0.74 |
01:24 ET | 26544 | 0.7445 |
01:26 ET | 33578 | 0.743 |
01:28 ET | 32300 | 0.743 |
01:30 ET | 208100 | 0.74505 |
01:32 ET | 10100 | 0.7451 |
01:33 ET | 3200 | 0.75 |
01:37 ET | 400 | 0.7566 |
01:39 ET | 100 | 0.7566 |
01:48 ET | 100 | 0.75 |
01:51 ET | 200 | 0.7562 |
02:00 ET | 227 | 0.75 |
02:02 ET | 200 | 0.75 |
02:04 ET | 716 | 0.75 |
02:06 ET | 100 | 0.75 |
02:08 ET | 1045 | 0.75 |
02:09 ET | 300 | 0.75 |
02:11 ET | 100 | 0.75 |
02:13 ET | 300 | 0.75 |
02:15 ET | 300 | 0.75 |
02:18 ET | 100 | 0.75 |
02:20 ET | 100 | 0.75 |
02:22 ET | 100 | 0.75 |
02:26 ET | 263 | 0.7405 |
02:27 ET | 300 | 0.7475 |
02:29 ET | 155 | 0.7406 |
02:31 ET | 400 | 0.7405 |
02:33 ET | 432 | 0.7405 |
02:40 ET | 200 | 0.741 |
02:42 ET | 100 | 0.741 |
02:44 ET | 300 | 0.741 |
02:45 ET | 300 | 0.7411 |
02:47 ET | 100 | 0.7542 |
02:51 ET | 200 | 0.7411 |
02:54 ET | 100 | 0.74775 |
02:56 ET | 200 | 0.7411 |
02:58 ET | 1000 | 0.74775 |
03:02 ET | 400 | 0.7411 |
03:03 ET | 204 | 0.7411 |
03:05 ET | 200 | 0.7542 |
03:07 ET | 1100 | 0.7412 |
03:09 ET | 100 | 0.7412 |
03:12 ET | 200 | 0.7478 |
03:16 ET | 300 | 0.7412 |
03:18 ET | 4084 | 0.7478 |
03:20 ET | 100 | 0.7542 |
03:21 ET | 200 | 0.7412 |
03:23 ET | 300 | 0.7478 |
03:27 ET | 827 | 0.75 |
03:30 ET | 300 | 0.7511 |
03:32 ET | 800 | 0.7547 |
03:34 ET | 483 | 0.7544 |
03:36 ET | 1401 | 0.756 |
03:38 ET | 5686 | 0.756 |
03:39 ET | 600 | 0.75605 |
03:41 ET | 1871 | 0.756 |
03:43 ET | 200 | 0.756 |
03:45 ET | 952 | 0.7599 |
03:48 ET | 1597 | 0.76 |
03:50 ET | 100 | 0.76 |
03:52 ET | 600 | 0.75992 |
03:54 ET | 300 | 0.76 |
03:57 ET | 221 | 0.76 |
03:59 ET | 2108 | 0.7612 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Allovir Inc | 87.5M | -0.5x | --- |
Verastem Inc | 87.9M | -0.8x | --- |
Cognition Therapeutics Inc | 86.9M | -2.4x | --- |
Connect Biopharma Holdings Ltd | 88.2M | -1.5x | --- |
Sellas Life Sciences Group Inc | 86.6M | -1.3x | --- |
IO Biotech Inc | 86.3M | -0.7x | --- |
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. Its technology and manufacturing process enable the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. Its lead product candidate, posoleucel, is a multi-VST therapy that targets six viruses: adenovirus (BKV), cytomegalovirus (EBV), human herpesvirus 6 (HHV-6) and JC virus (JCV). Its proprietary VST manufacturing platform enables the rapid, robust and reproducible generation of single-virus and multi-virus specific cell therapeutic candidates for clinical use.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $87.5M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 115.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-1.65 |
Book Value | $1.28 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.